Strateos, a DCVC/Lux Capital investment, is a pioneer in the development of remote access laboratories and lab automation software for life sciences discovery.
In 2021, Occam recruited David Lynch as the company’s CBO. Previously, David served as the VP of Business Development at Premier Research. Prior to his stint at Premier Research, David held various Business Development roles at biotechnology vendors & equipment manufacturers, such as PerkinElmer and Affymetrix.
